We believe that providing early career opportunities to diverse and representative populations is key to enriching our industry and driving innovation. Recently, we partnered with MassBioEd Foundation's The LEAH Project to host a visit to our Cambridge office, where students engaged in tours of our labs, learned about drug development during a #BlueCrew panel and more. The LEAH Project is dedicated to addressing inequities in education by opening STEM opportunities to youth from marginalized groups. We're proud to support their mission to enable and empower the talent of tomorrow.
Blueprint Medicines
Biotechnology Research
Cambridge, Massachusetts 48,296 followers
Striving to improve and extend patients' lives
About us
Blueprint Medicines is a global, fully integrated biopharmaceutical company that invents life-changing medicines. We seek to alleviate human suffering by solving important medical problems in two core focus areas: allergy/inflammation and oncology/hematology. Our approach begins by targeting the root causes of disease, using deep scientific knowledge in our core focus areas and drug discovery expertise across multiple therapeutic modalities. We have a proven track record of success with two approved medicines in the U.S. and Europe. Leveraging our established research, development, and commercial capability and infrastructure, we now aim to significantly scale our impact by advancing a broad pipeline of programs ranging from early science to advanced clinical trials in mast cell diseases including systemic mastocytosis and chronic urticaria, breast cancer and other solid tumors. Patients are at the center of our mission. We know that in order to make a difference in their lives, we must create an environment where our employees — also known as the Blue Crew — can do their best work. Our culture of transparency, curiosity and diversity empowers us to draw upon a wide range of backgrounds and perspectives to build a conscientious team dynamic. Ideas come from every member of the Blue Crew, from the executive team to new hires. Each day, our teams commit to approach one another with respect and trust: a simple promise that fosters an inclusive and collaborative spirit. We care deeply about the communities where we live and work, and we strive to make a profound impact where it matters most. Learn more about who we are and explore our career opportunities at https://www.blueprintmedicines.com/careers/. Read our community guidelines: https://www.blueprintmedicines.com/community-guidelines/.
- Website
-
http://www.blueprintmedicines.com
External link for Blueprint Medicines
- Industry
- Biotechnology Research
- Company size
- 501-1,000 employees
- Headquarters
- Cambridge, Massachusetts
- Type
- Public Company
- Founded
- 2011
- Specialties
- targeted therapy, systemic mastocytosis, breast cancer, allergy/inflammatory, hematology/oncology, solid tumors, drug design, and mast cell biology
Locations
-
Primary
Get directions
45 Sidney St
Cambridge, Massachusetts 02139, US
-
Get directions
Baarerstrasse 8
Zug, 6300, CH
Employees at Blueprint Medicines
Updates
-
Today, we announced our Q2 2024 financial results. Join our live investor webcast at 8 a.m. ET or read our press release here: https://bit.ly/4fpJZ1j
-
-
Our core value of Urgency focuses on solving complex problems rapidly with attention and care. Across our Research and Development teams, including from discovery to medical affairs, the #BlueCrew works with Urgency to propel innovation and positively impact the lives of patients in need. Click through to learn how #BlueCrew members Sunitha Rangaraju, Ph.D. and Joseph Kim bring this value to life in their everyday work.
-
-
Congratulations to Percy Carter, our Chief Scientific Officer, for being appointed to the Board of Directors at Cellarity. Percy will bring his leadership in drug discovery and platform development to the Board, and he shares, “I am delighted to join the Board of Directors at Cellarity as the company sets out to challenge the status quo of drug discovery with its unique platform, ultimately bringing value to patients via novel biology and differentiated drug candidates.”
-
-
Sharing the lived experiences of people with serious diseases increases compassion and understanding among family, friends, and healthcare providers. Check out this WRTV feature about the launch of our novel art program, ‘Colors of SM: Expressions of Life with Systemic Mastocytosis,’ in collaboration with Twist Out Cancer, which aims to shed light on the real-world impacts of SM and the resilience and hopes of people living with it. #ColorsOfSM
-
This #NationalInternDay, we're celebrating the contributions of this year's intern cohort and their meaningful impact across our organization. We believe in supporting young talent through inclusive early career programs that bring fresh perspectives into our company and the life sciences industry. Join Erin Lopez, our Human Resources Intern, as she shares a day in her life as a summer intern in our Cambridge office.
-
Our responsibility to help patients goes beyond delivering innovative treatments. Through personalized patient support and extensive education programs, we strive to understand the holistic experience of living with SM and tailor the assistance we provide to meet patients' diverse needs, enabling them to navigate their health with knowledge and confidence.
-
Jennifer has turned the vulnerability she’s experienced from living with systemic #mastocytosis (SM) into her superpower. Michele, an artist who helped Jennifer express her experience through art, is inspired by her enduring love of life and willingness to face constant challenges in her desire to be free. At our inaugural Colors of SM event on Friday, we unveiled the artwork they created together in an exhibit featuring pieces from 6 individual pairings. In collaboration with Twist Out Cancer, the Colors of SM program aims to bring to life the real-world impacts of SM, increasing compassion and understanding. For more information, visit the #ColorsOfSM website: https://lnkd.in/e5KdnJDq
-
We’ve wrapped up an inspiring weekend at The Mast Cell Disease Society, Inc.’s #MastCellCon. This event hosted patients, caregivers, advocates, HCPs and more in person and online to discuss latest research, innovation and education in mast cell diseases. We’re deeply committed to supporting people living with systemic mastocytosis, increasing understanding of the disease and raising awareness of patients’ experiences. Check out our #BlueCrew at the event and read more from Fatima Scipione, VP of Global Patient Affairs, below: https://shorturl.at/tAnAu
-
Creating a shared understanding of the real-world impacts of systemic mastocytosis (SM) is crucial to support and empower those living with the disease. Today, we're unveiling an inaugural art exhibit from our 'Colors of SM: Expressions of Life with Systemic Mastocytosis' program, which illuminates the experiences of people living with SM through the transformative power of creative arts. In collaboration with Twist Out Cancer, Colors of SM pairs talented artists with individuals living with SM to create a unique work of art that reflects their personal journey with the disease. #ColorsOfSM Read more: https://bit.ly/3W4bDIa
-
Similar pages
Browse jobs
Stock
BPMC
NASDAQ
20 minutes delay
$96.72
-3.57 (-3.56%)
- Open
- 96.38
- Low
- 95.5
- High
- 99.31
Data from Refinitiv
See more info on